Company Filing History:
Years Active: 2013-2016
Title: Lucia Beviglia: Innovator in Melanoma Treatment
Introduction
Lucia Beviglia is a prominent inventor based in Redwood City, California. She has made significant contributions to the field of oncology, particularly in the treatment of melanoma. With a total of two patents to her name, her work focuses on innovative methods to combat this aggressive form of skin cancer.
Latest Patents
Lucia's latest patents detail methods for treating melanoma. These include methods of inhibiting melanoma tumor growth, treating both melanoma and metastatic melanoma, and reducing the frequency of tumor-initiating cells, also known as cancer stem cells, in melanoma tumors. The described methods involve administering a DLL4 antagonist, such as an antibody that specifically binds to the extracellular domain of human DLL4, to a subject. Additionally, her patents cover related polypeptides and polynucleotides, compositions that include DLL4 antagonists, and methods for producing these antagonists.
Career Highlights
Lucia Beviglia is currently associated with Oncomed Pharmaceuticals, Inc., where she continues to advance her research and development efforts in cancer treatment. Her work has been instrumental in exploring new therapeutic avenues for patients suffering from melanoma.
Collaborations
Lucia collaborates with Timothy Charles Hoey, contributing to the innovative research environment at Oncomed Pharmaceuticals, Inc. Their combined expertise enhances the potential for breakthroughs in melanoma treatment.
Conclusion
Lucia Beviglia's contributions to melanoma treatment through her innovative patents and collaborative efforts position her as a key figure in the fight against cancer. Her work exemplifies the impact of dedicated research in improving patient outcomes.